Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent Academic Article uri icon

Overview

MeSH Major

  • Nomograms
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • An accurate tool was developed for predicting the probability that a man with clinically localized prostate cancer will survive his disease for 120 months if the cancer is not treated with curative intent immediately. The tool should be helpful for patient counseling and clinical trial design.

publication date

  • January 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3390682

Digital Object Identifier (DOI)

  • 10.1002/cncr.23106

PubMed ID

  • 18000803

Additional Document Info

start page

  • 69

end page

  • 74

volume

  • 112

number

  • 1